Results 61 to 70 of about 1,535 (117)

Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations. [PDF]

Eur J Hosp Pharm
Jambon A, Forat M, Marchand C, Morel C, Merienne C, Filali S, Pirot F.   +6 more
europepmc   +1 more source

Possible manufacture of test allergens in public pharmacies for the diagnosis of type I allergies: Legal aspects. [PDF]

Allergol Select
Jost R, Kespohl S, Paulus-Tremel KE, Zimmer J, Bonertz A, Sander I, Klose T, Altin LM, Heller S, Heimke-Brinck R, Dörje F, Philippus S, Meyer M, Segebrecht S, Wessel T, Starke D, Schülke S, Raulf M, Mahler V.   +18 more
europepmc   +1 more source

Advice to the US FDA to Allow US Pharmacopeia to Create Biological Product Specifications (BPS) to Remove Side-by-Side Analytical Comparisons of Biosimilars with Reference Products. [PDF]

Pharmaceutics
Niazi SK.
europepmc   +1 more source

Danish ban on Ashwagandha: Truth, evidence, ethics, and regulations. [PDF]

J Ayurveda Integr Med
Patwardhan B, Chaturvedi S, Tillu G, Deshpande S, Hegde BM.   +4 more
europepmc   +1 more source

Extemporaneous Formulations for Pediatric Patients: Global Necessities, Challenges and Opportunities. [PDF]

Pharmaceutics
Pai VB, Nahata MC.
europepmc   +1 more source

Efficacy of a Modified-Live Virus Combination Vaccine (CDV, CAV, CPV, CPiV), Canigen^TM DHPPi, in Puppies Vaccinated at Six Weeks of Age. [PDF]

Viruses
Loukeri S, Senseby F, Benizeau E, Cronier J, Gueguen S.   +4 more
europepmc   +1 more source

Chemistry, manufacturing, and controls for live microbial products: addressing classification challenges and enhancing process validation. [PDF]

Front Microbiomes
Slijkerman R, van Dijk R, Mohieddin N, Ciarlante I, de Jong A, Schuler MM.   +5 more
europepmc   +1 more source

Dietary Supplement Adulteration: Laboratory Approaches to Risk Mitigation. [PDF]

J Nat Prod
Ma C, Monagas M, Bronstein L, Cadwallader A, Goldman V.   +4 more
europepmc   +1 more source

Development of an automated method for in-house production of sodium ¹⁸F-fluoride for injection: process validation as a step toward routine clinical application. [PDF]

EJNMMI Radiopharm Chem
Atanasova Lazareva M, Chochevska M, Kolevska K, Velickovska M, Jolevski F, Apostolova P, Ugrinska A, Janevik-Ivanovska E.   +7 more
europepmc   +1 more source

Quality evaluation of cephalexin, cefuroxime, and ceftriaxone medicines marketed in Addis Ababa city, Ethiopia with three tier level approach and anti-microbial assays. [PDF]

BMC Pharmacol Toxicol
Birhane W, Getachew T, Bitew M, Mitiku M, Abera T, Eticha T, Ashenef A.   +6 more
europepmc   +1 more source